announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise
Benefits of Weight Loss on Menstrual Health In addition to regulating oestrogen, healthy weight loss brings broader benefits to menstrual health
recent studies show that locally secreted GLP-1 can activate GLP-1 receptor-expressing afferent fibers of the glossopharyngeal and vagal nerves, thereby transmitting peripheral gustatory information to the NTS
Add 4 and two are half off, and so on
Foundayo (orforglipron) is one of the first medicines to be approved after going through the FDA's super-rapid national priority review voucher programme, reducing the FDA's review timeline to a matter of weeks
Diabetes has what I would think is a more significant potential for long-term damage